Abstract:BackgroundRational engineering studies for deoxycytidine production were initiated due to low intracellular levels and tight regulation. To achieve high-level production of deoxycytidine, a useful precursor of decitabine, genes related to feed-back inhibition as well as the biosynthetic pathway were engineered. Additionally, we predicted the impact of individual gene expression levels on a complex metabolic network by microarray analysis. Based on these findings, we demonstrated rational metabolic engineering strategies capable of producing deoxycytidine.ResultsTo prepare the deoxycytidine producing strain, we first deleted 3 degradation enzymes in the salvage pathway (deoA, udp, and deoD) and 4 enzymes involved in the branching pathway (dcd, cdd, codA and thyA) to completely eliminate degradation of deoxycytidine. Second, purR, pepA and argR were knocked out to prevent feedback inhibition of CarAB. Third, to enhance influx to deoxycytidine, we investigated combinatorial expression of pyrG, T4 nrdCAB and yfbR. The best strain carried pETGY (pyrG-yfbR) from the possible combinatorial plasmids. The resulting strain showed high deoxycytidine yield (650 mg/L) but co-produced byproducts. To further improve deoxycytidine yield and reduce byproduct formation, pgi was disrupted to generate a sufficient supply of NADPH and ribose. Overall, in shake-flask cultures, the resulting strain produced 967 mg/L of dCyd with decreased byproducts.ConclusionsWe demonstrated that deoxycytidine could be readily achieved by recombineering with biosynthetic genes and regulatory genes, which appeared to enhance the supply of precursors for synthesis of carbamoyl phosphate, based on transcriptome analysis. In addition, we showed that carbon flux rerouting, by disrupting pgi, efficiently improved deoxycytidine yield and decreased byproduct content.

Enhanced Cytidine Production by a Recombinant Escherichia Coli Strain Using Genetic Manipulation Strategies

Enhancement of Cytidine Production by Coexpression of Gnd, Zwf, and Prs Genes in Recombinant Escherichia Coli Cyt15

Study on Cytidine Producing Strain Based on Cdd Gene Knockout and Pyrimidine Operon Transfer

Improving the level of the cytidine biosynthesis in E. coli through atmospheric room temperature plasma mutagenesis and metabolic engineering

Overexpression of Uracil Permease and Nucleoside Transporter from Bacillus Amyloliquefaciens Improves Cytidine Production in Escherichia Coli.

Modularized Reconstruction of Pyrimidine Pathway in Escherichia Coli for Enhanced Pyrimidine Nucleosides Biosynthesis

Deoxycytidine production by a metabolically engineered Escherichia coli strain

Effects of Medium Components and Fermentation Conditions on Cytidine Production by Recombinant Escherichia Coli Cyt20

Deoxycytidine production by metabolically engineered Corynebacterium ammoniagenes

Increased Distribution of Carbon Metabolic Flux During De Novo Cytidine Biosynthesis Via Attenuation of the Acetic Acid Metabolism Pathway in Escherichia Coli

The Effect of E. Coli Uridine-Cytidine Kinase Gene Deletion on Cytidine Synthesis and Transcriptome Analysis

Screening of Cytidine-Producing Mutants Based on Feedback-Inhibition Resistance of CTP Synthetase

Improvement of Cephalosporin C Production by Recombinant DNA Integration in Acremonium Chrysogenum

[Metabolic engineering of Escherichia coli for thymidine production]

The New Strategy of Breeding Cytidine Excessive Biosynthesis Mutants by pyr Operon Rearrangement of Bacillus amyloliquefaciens

Heterologous erythromycin production across strain and plasmid construction

Site-directed Mutagenesis Studies on the Uridine Monophosphate Binding Sites of Feedback Inhibition in Carbamoyl Phosphate Synthetase and Effects on Cytidine Production by Bacillus Amyloliquefaciens.

Multistep construction of metabolically engineered Escherichia coli for enhanced cytidine biosynthesis

Application of Auto-induction System in the Synthesis of 2’-deoxycytidine

Improvement of uridine production in Bacillus subtilis by metabolic engineering

High-level living cell production of cytidine-5′-diphosphocholine in metabolically engineered yeast